4.0
2. Feb. 2026
Ehemaliger Mitarbeiter, weniger als 1 Jahr
San Diego, CA
Empfehlen
CEO-Befürwortung
Geschäftsprognose
Pros
CGM's are very useful for diabetics and are becoming more commonplace. It was great to be part of creating such a useful tool. Also, I got to work with a lot of very intelligent people.
Kontras
Dexcom doesn't have a large portfolio of products. While CGM's are becoming more common, there is a lot more competition in the market right now.